Advertisement
Advertisement

More Related Content

Advertisement
Advertisement

Preoperative preparation of high risk patients.pptx

  1. Preoperative preparation for High-Risk Surgical Patients Dr. Nabarun Biswas Registrar Surgery MMCH
  2. Pre-op Preparation in General 1. Evaluation of physical fitness 2. Correction of  I. Anaemia (Hb% > 8gm/dl) II. Dehydration III. Nutrition IV. Electrolytes V. coagulopathy
  3. Pre-op Preparation in General 3. Prophylaxis of I. Antibiotics II. DVT III. tetanus 4. Diet : I. Adult a. Solid for 6 hr before surgery b. Clear fluid for 2 hr before surgery II. Infant & child a. Solid/ formula/ cow milk 6 hr before surgery b. Mothers milk 3 hrs c. Clear fluid 2 hrs
  4. Pre-op Preparation in General 5. Shaving & cleaning of operative site 6. Arrangement of blood transfusion/ frozen section biopsy/ imaging 7. Informed consent 8. Control of DM, HTN, Infection, COPD
  5. Common High-Risk Patients • DM • DVT • Anti-coagulant use • MI • HTN • COPD • Steroid • Thyroid function abnormality • Adrenal insufficiency • Pheochromocytoma
  6. Diabetes mellitus • Aim: to maintain blood sugar 6-12 mmol/li • Patient type: –Controlled by diet –Controlled by oral drugs –Controlled by insulin Short acting Long acting  converted to short acting (starting dose of short acting insulin is 0.2 – 0.4 unit/kg BW)
  7. Diabetes mellitus Sl Controlled by Minor surgery Major surgery 1 Diet Nonspecific If blood sugar > 12 mmol/li start GKI regimen 2 Oral drug -Omit morning dose -Strat when eating normally Omit Metformin 24 hrs before surgery Omit glimepiride 48 hrs before surgery If blood sugar > 12 mmol/li start GKI regimen 3 Insulin -Convert to short acting before surgery -During surgery start GKI -Continue till NPO Per-operative
  8. Diabetes mellitus Post operative: 1. Patients on oral drugs  Subcutaneous short acting for few days then oral drug continue 2. Patients on insulin  After omitting NPO short acting insulin for 3 days then original regimen
  9. GKI regimen • Infusion 1: – 500 ml 10% DA + 10 mmol KCL (100 ml/hr i.e., 25 d/m) • Infusion 2: – 50 ml NS + 50 unit short Acting insulin (taken in 50 cc syringe & connected with insulin driver) Blood sugar mmol/li Push driver / hr <5 Off 5-7 1 ml/hr 7-10 2 ml/hr 10-20 3ml/hr >20 4ml/hr Sliding Scale
  10. DVT prophylaxis • Pre-operative I. Weight reduction II. Stop OCP 1 month before surgery III. If any risk factor  manage accordingly • Peri-operative a. Mechanical  Graduated compression stocking  Intermittent pneumatic compression  Electrical calf muscle stimulation
  11. DVT prophylaxis b. Pharmacological  Low ml wt Heparin 40 mg/day, S/C for 5 days  started 12 hr before surgery & continued up to 5th POD • Post operative: – Early mobilization – Calf muscle exercise – Graduated stocking – Adequate hydration
  12. Stablished DVT • Anticoagulant therapy o Low mol wt Heparin S/C for 5-7 days + Oral Warfarin (10 mg in day 1, 10 mg on day 2 & 5 mg on day 3  up to 3-6 months ) o PT & INR should be measured daily o PT 1.5 to 2.5 times o INR  2.5 to 3.5 times • Thrombolysis: streptokinase  direct administration into thrombus • Stent grafting: IVC filter • Surgery: thrombectomy with A-V fistula
  13. Patients on Anticoagulants Agent used 1. Oral anticoagulant: Warfarin 2. Injectable: Heparin 3. Antiplatelet: Aspirin, clopidogrel
  14. Patients on Anticoagulants A. Warfarin: • Emergency operation: I. Inj Vit K I/V II. FFP III. Factor 2, 7, 9, 10 (prothrombin complex) transfusion • Elective operation: I. Stopped 5 days before surgery II. If INR < 1.5  L.M. Heparin S/C  stopped 2hr before surgery III. Post op heparin for 3 days  oral warfarin
  15. Patients on Anticoagulants B. Heparin:  Emergency operation: I. Neutralized by Protamine sulphate II. PT in maintained within 1.5 to 2.5  Elective operation: I. Stopped 4-6 hrs before surgery C. Antiplatelet: I. Aspirin: stopped 7 days before surgery II. Clopidogrel: stopped 10 days before surgery NB: if coagulation risk is high Aspirin may be continued
  16. Patients with MI A. Preoperative I. Postpone surgery if recent MI within 6 months II. If angina β blocker + GTN B. Per operative I. Anaesthetist must avoid any condition that increase myocardial O2 demand: tachycardia, HTN, hypotension II. Avoid Atropine (causes tachycardia) III. Use halothane C. Postoperative I. Adequate analgesia II. Regular ABG III. Cardiac monitoring
  17. Patients with HTN A. Preoperative  Anti HTN drugs (diuretics, β blocker, Ca ch blocker, ACE inhibitor)  Anti HTN drugs taken up to morning dose B. Per operative  Propranolol may be used to control HTN C. Post operative  Adequate analgesia  Regular ABG  Cardiac monitoring
  18. Patients with COPD A. Preoperative I. Stop smoking 4-6 weeks before surgery II. Bronchodilator  continue III. Steroid  continue B. Per operative I. Additional dose of steroid II. Monitoring of O2 saturation III. Inj hydrocortisone @ induction
  19. Patients with COPD C. Post operative I. Clearance of airway II. O2 inhalation by O2 mask III. Nebulization IV. Inj hydrocortisone 6 hrly for 3 days  tapper V. Chest physiotherapy VI. Early ambulation VII.Adequate analgesia
  20. Steroid user Preparation for surgery: 1. Short procedure e.g. Endoscopy  single dose injectable 2. Minor surgery  single dose preoperative + another dose 12 hrs later 3. Major surgery  • Elective  stop 2 months before with tapering dose • Emergency  inj Hydrocortison I/V @ induction then 6 hrly for 3 days
  21. Steroid user Additional management: 1. Control of DM 2. Control of infection 3. Control of HTN 4. Exercise & physiotherapy
  22. Hypothyroidism For elective surgery Aim: to achieve euthyroid state  –Levothyroxine 25 μgm /day –Gradually increase up to 150 – 200 μgm /day For emergency surgery – Levothyroxine 500 μgm I/V or Orally N.B: before administration of Levothyroxine check if the patient is suffering from Addison’s disease or Coronary Artery disease.
  23. Hyperthyroidism Aim: to achieve euthyroid state  A. For elective surgery: 1. Carbimazole:  30-40 mg /day for 8-12 weeks {10 mg TDS}  When patient becomes euthyroid reduce the dose 15 mg / day  Last dose give evening before surgery 2. Lugols Iodin:  Started 10-14 days before surgery  5 drops TDS with milk  Or, potassium iodide tablet 60 mg TDS
  24. Hyperthyroidism B. For rapid control: {A+B} 1. Tab. Propranolol  40 mg TDS  Continue up to 7th POD or, 2. Tab. Nindolol  80 mg TDS
  25. Management of Thyroid Storm CF: Dehydration Hyperthermia Restlessness Shock Cardiac failure
  26. Management of Thyroid Storm A. General Mx:  I/V fluid  Cooling by ice pack  Sedation  Diuretics if cardiac failure  Digoxin Fibrilation  hydrocortison B. Specific Mx:  carbimazole 10-20 mg QDS  Lugols Iodin 10 drops TDS  Propranolol  40 mg QDS
  27. Pheochromocytoma Preparation of patient: 1. α Blocker: Phenoxy Benzamine  20-40 mg /day  Gradually increase 10 mg /day  up to patient complains about postural hypotension or dose reached 100-160 mg /day. 2. β Blocker: Propranolol  After blocking α receptor, β Blocker started  40 mg TDS 3. Preoperative extra fluid overload to be done to prevent hypovolemia after removing the tumor.
  28. Pheochromocytoma Precaution: 1. CV line for invasive monitoring 2. IV α Blocker 3. IV β Blocker 4. IV peripheral vasodilator 5. Tumor handled gently 6. Vein ligated first
  29. Pheochromocytoma Post operative: First 24 hrs should be in ICU Monitoring of hypoglycaemia Monitoring of hypotension
Advertisement